Storen Legacy Partners LLC Makes New Investment in Danaher Corporation $DHR

Storen Legacy Partners LLC purchased a new stake in Danaher Corporation (NYSE:DHR) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 14,674 shares of the conglomerate’s stock, valued at approximately $3,359,000. Danaher accounts for approximately 1.1% of Storen Legacy Partners LLC’s holdings, making the stock its 14th biggest holding.

Other large investors also recently made changes to their positions in the company. Elevated Capital Advisors LLC bought a new stake in Danaher in the 4th quarter valued at $26,000. Hilton Head Capital Partners LLC bought a new position in Danaher during the 4th quarter worth about $27,000. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the period. JPL Wealth Management LLC bought a new stake in shares of Danaher in the third quarter valued at about $25,000. Finally, WFA of San Diego LLC bought a new stake in shares of Danaher in the second quarter valued at about $26,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.3%

DHR stock opened at $177.74 on Friday. The company has a market cap of $125.80 billion, a price-to-earnings ratio of 34.38, a P/E/G ratio of 2.26 and a beta of 0.81. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The business has a 50 day moving average price of $179.62 and a two-hundred day moving average price of $203.07. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.88 EPS. Analysts anticipate that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Morgan Stanley decreased their price objective on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. DZ Bank began coverage on Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target for the company. JPMorgan Chase & Co. decreased their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. Evercore lifted their price objective on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a report on Tuesday, April 21st. Finally, Piper Sandler started coverage on shares of Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.